Equillium Inc.(EQ)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

EQ Equillium Inc.

盘后交易 02-12 18:47:09 EST

1.60

+0.05

+3.23%

盘后1.64

+0.04+2.50%

18:42 EST

最高1.69	最低1.55	成交量65.49万
今开1.55	昨收1.55	日振幅9.03%
总市值9,743万	流通市值6,964万	总股本6,089万
成交额105.84万	换手率1.50%	流通股本4,352万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"EQ","market":"US","secType":"STK","nameCN":"Equillium Inc.","latestPrice":1.6,"timestamp":1770930000000,"preClose":1.55,"halted":0,"volume":654851,"hourTrading":{"tag":"盘后","latestPrice":1.64,"preClose":1.6,"latestTime":"18:42 EST","volume":223,"amount":357.4000261,"timestamp":1770939737379,"change":0.04,"changeRate":0.025,"amplitude":0.025},"delay":0,"changeRate":0.03225806451612906,"floatShares":43524300,"shares":60893283,"eps":-0.58,"marketStatus":"盘后交易","change":0.05,"latestTime":"02-12 18:47:09 EST","open":1.55,"high":1.69,"low":1.55,"amount":1058370.5791106,"amplitude":0.090323,"askPrice":1.68,"askSize":1,"bidPrice":1.63,"bidSize":48,"shortable":3,"etf":0,"ttmEps":-0.58,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1770944400000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1539316800000,"exchange":"NASDAQ","adjPreClose":1.55,"postHourTrading":{"tag":"盘后","latestPrice":1.64,"preClose":1.6,"latestTime":"18:42 EST","volume":223,"amount":357.4000261,"timestamp":1770939737379,"change":0.04,"changeRate":0.025,"amplitude":0.025},"volumeRatio":1.270711,"impliedVol":1.6002,"impliedVolPercentile":0.8287},"requestUrl":"/m/hq/s/EQ/tweets","defaultTab":"tweets","newsList":[{"id":"2602341763","title":"Equillium, Inc.盘中异动 大幅下跌5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602341763","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602341763?lang=zh_cn&edition=full","pubTime":"2026-01-08 22:45","pubTimestamp":1767883509,"startTime":"0","endTime":"0","summary":"北京时间2026年01月08日22时45分，Equillium, Inc.股票出现异动，股价急速下跌5.34%。Equillium, Inc.股票所在的生物技术行业中，整体跌幅为0.30%。Equillium, Inc.公司简介：Equillium Inc是一家临床阶段的生物技术公司，致力于开发新的治疗方法，以治疗严重的自身免疫性和炎症性疾病，或免疫炎症性疾病，具有高度未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108224509a4ac8534&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108224509a4ac8534&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","EQ","BK4568"],"gpt_icon":0},{"id":"2601335184","title":"Equillium, Inc.盘中异动 快速拉升5.27%报1.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601335184","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601335184?lang=zh_cn&edition=full","pubTime":"2026-01-07 22:35","pubTimestamp":1767796503,"startTime":"0","endTime":"0","summary":"北京时间2026年01月07日22时35分，Equillium, Inc.股票出现异动，股价急速拉升5.27%。截至发稿，该股报1.36美元/股，成交量2.6366万股，换手率0.04%，振幅3.10%。Equillium, Inc.股票所在的生物技术行业中，整体涨幅为0.65%。Equillium, Inc.公司简介：Equillium Inc是一家临床阶段的生物技术公司，致力于开发新的治疗方法，以治疗严重的自身免疫性和炎症性疾病，或免疫炎症性疾病，具有高度未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107223504a6ff2b23&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107223504a6ff2b23&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EQ","BK4568","BK4139"],"gpt_icon":0},{"id":"2588018744","title":"七座版奔驰GLC EQ首曝：车身加长 迎合中国市场需求","url":"https://stock-news.laohu8.com/highlight/detail?id=2588018744","media":"IT之家","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588018744?lang=zh_cn&edition=full","pubTime":"2025-12-03 14:11","pubTimestamp":1764742281,"startTime":"0","endTime":"0","summary":"IT之家 12 月 3 日消息，汽车媒体 CarScoops 昨日 发布博文，报道称在慕尼黑车展发布 GLC EQ 五座版后，梅赛德斯-奔驰斯正在测试一款体型更大、采用三排七座的变体车型。外观方面，七座版 GLC EQ 延续了标准版的设计语言，但在 B 柱之后进行了显著调整。该媒体认为，这款三排座纯电跨界车主要是为了迎合中国市场对大空间、多座位车型的偏好而设计。IT之家附上相关图片如下：","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8omctTD8nZW","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"fenghuang_stock","symbols":["BK4568","BK4588","CHAU","YINN","BK4585","MCHI","ASHR","CWEB","CQQQ","FXI","KWEB","ASHS","BK4614","BK4139","EQ","DRAG"],"gpt_icon":1},{"id":"2580789280","title":"Equillium, Inc.盘中异动 股价大涨5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580789280","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580789280?lang=zh_cn&edition=full","pubTime":"2025-11-03 22:59","pubTimestamp":1762181985,"startTime":"0","endTime":"0","summary":"北京时间2025年11月03日22时59分，Equillium, Inc.股票出现波动，股价急速上涨5.32%。Equillium, Inc.股票所在的生物技术行业中，整体跌幅为0.53%。Equillium, Inc.公司简介：Equillium Inc是一家临床阶段的生物技术公司，致力于开发新的治疗方法，以治疗严重的自身免疫性和炎症性疾病，或免疫炎症性疾病，具有高度未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251103225946a6de31ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251103225946a6de31ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4139","EQ"],"gpt_icon":0},{"id":"2567186498","title":"奔驰确认将逐步弃用“EQ”品牌，未来转向“Electric”命名","url":"https://stock-news.laohu8.com/highlight/detail?id=2567186498","media":"IT之家","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567186498?lang=zh_cn&edition=full","pubTime":"2025-09-13 12:18","pubTimestamp":1757737090,"startTime":"0","endTime":"0","summary":"IT之家 9 月 13 日消息，梅赛德斯-奔驰长期以来在电动车型上使用 EQ 子品牌，并推出了 EQS、EQE 轿车及其 SUV 版本。奔驰首席技术官 Markus Schfer 本周二在接受《新闻周刊》采访时确认，公司将逐步放弃 EQ 标识，转而使用“Electric”作为新命名。IT之家提醒，“Electric”对应的中文名可能类似于纯电 CLA、纯电 GLC 这种带有“纯电”的词缀。Schfer 表示：我们正在转向使用 Electric 这一名称。奔驰并不会马上切换命名。奔驰官网的未来车型页面上仍显示 2027 款 GLC with EQ Technology。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8mc2kBWeQTg","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fenghuang_stock","symbols":["BK4568","BK4139","EQ"],"gpt_icon":0},{"id":"1138387172","title":"Equillium Inc申请发行最多5263万股普通股 现有股东出售 - SEC备案文件","url":"https://stock-news.laohu8.com/highlight/detail?id=1138387172","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1138387172?lang=zh_cn&edition=full","pubTime":"2025-09-10 05:03","pubTimestamp":1757451784,"startTime":"0","endTime":"0","summary":"Equillium Inc根据美国证监会备案文件申请发行最多5263万股普通股，由现有股东进行出售。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","EQ","BK4568"],"gpt_icon":0},{"id":"2564305542","title":"Equillium, Inc.盘中异动 早盘急速跳水5.35%报1.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2564305542","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564305542?lang=zh_cn&edition=full","pubTime":"2025-09-04 23:05","pubTimestamp":1756998332,"startTime":"0","endTime":"0","summary":"北京时间2025年09月04日23时05分，Equillium, Inc.股票出现异动，股价快速下跌5.35%。截至发稿，该股报1.77美元/股，成交量13.7785万股，换手率0.39%，振幅4.81%。Equillium, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。Equillium, Inc.公司简介：Equillium Inc是一家临床阶段的生物技术公司，致力于开发新的治疗方法，以治疗严重的自身免疫性和炎症性疾病，或免疫炎症性疾病，具有高度未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250904230532a70fe70d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250904230532a70fe70d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4568","EQ"],"gpt_icon":0},{"id":"1122602412","title":"Equillium Inc根据纳斯达克上市规则5635(C)(4)报告诱导授予","url":"https://stock-news.laohu8.com/highlight/detail?id=1122602412","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122602412?lang=zh_cn&edition=full","pubTime":"2025-09-04 06:01","pubTimestamp":1756936864,"startTime":"0","endTime":"0","summary":"Equillium Inc宣布根据纳斯达克上市规则5635(C)(4)进行诱导授予。该规则要求上市公司对特定类型的员工激励计划进行适当披露和报告。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EQ","BK4568","BK4139"],"gpt_icon":0},{"id":"2518372274","title":"Equillium, Inc.盘中异动 早盘大幅下挫8.13%报0.731美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518372274","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518372274?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:56","pubTimestamp":1741614969,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时56分，Equillium, Inc.股票出现异动，股价大幅下跌8.13%。截至发稿，该股报0.731美元/股，成交量4859股，换手率0.01%，振幅3.64%。Equillium, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Mineralys Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为2936.57%、644.95%、177.16%，振幅较大的相关个股有Scisparc Ltd.、Dogwood Therapeutics, Inc.、Impact Biomedical, Inc.，振幅分别为40.24%、30.52%、28.59%。Equillium, Inc.公司简介：Equillium Inc 是一家开发治疗自身免疫和炎症疾病的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310215610abf305cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310215610abf305cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","EQ","BK4139"],"gpt_icon":0},{"id":"2517193777","title":"Equillium, Inc.盘中异动 快速拉升5.57%报0.760美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517193777","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517193777?lang=zh_cn&edition=full","pubTime":"2025-03-07 01:26","pubTimestamp":1741282006,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日01时26分，Equillium, Inc.股票出现波动，股价快速上涨5.57%。截至发稿，该股报0.760美元/股，成交量2.5922万股，换手率0.07%，振幅7.92%。Equillium, Inc.股票所在的生物技术行业中，整体跌幅为0.78%。Equillium, Inc.公司简介：Equillium Inc 是一家开发治疗自身免疫和炎症疾病的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307012646963c6cac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307012646963c6cac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","EQ","BK4139"],"gpt_icon":0},{"id":"2516663928","title":"Equillium, Inc.盘中异动 股价大跌5.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516663928","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516663928?lang=zh_cn&edition=full","pubTime":"2025-03-04 04:37","pubTimestamp":1741034264,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日04时37分，Equillium, Inc.股票出现波动，股价大幅下挫5.73%。Equillium, Inc.股票所在的生物技术行业中，整体跌幅为0.18%。其相关个股中，Abpro Holdings Inc C/Wts 12/11/2029 、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Celularity Inc C/Wts 16/07/2026 涨幅较大，Allarity Therapeutics, Inc.、Entero Therapeutics Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为215.52%、187.68%、163.60%，振幅较大的相关个股有Radiopharm Theranostics Limited、Entero Therapeutics Inc.、Celularity Inc C/Wts 16/07/2026 ，振幅分别为119.50%、70.53%、64.88%。Equillium, Inc.公司简介：Equillium Inc 是一家开发治疗自身免疫和炎症疾病的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503040437449637fdc0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503040437449637fdc0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","EQ","BK4568"],"gpt_icon":0},{"id":"2514680753","title":"OpenAI发布GPT-4.5！史上最贵AI模型，情商逆天引热议，AI巨头混战即将打响","url":"https://stock-news.laohu8.com/highlight/detail?id=2514680753","media":"金融界","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514680753?lang=zh_cn&edition=full","pubTime":"2025-02-28 08:49","pubTimestamp":1740703799,"startTime":"0","endTime":"0","summary":"2月28日凌晨，OpenAI正式发布了其最新一代基础模型GPT-4.5，这一发布迅速在科技界引起了轩然大波。这款被OpenAI内部代号为“Orion”的模型，不仅被誉为迄今为止规模最大、知识最丰富的聊天模型，更因其高情商和人性化表现而备受瞩目。价格昂贵，引发争议然而，GPT-4.5的高昂价格也成为了人们热议的话题。值得一提的是，OpenAI还计划在未来向免费用户开放GPT-5的使用权限。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/02/28084948444186.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK4568","EQ","BK4139"],"gpt_icon":0},{"id":"2514354332","title":"实测GPT4.5：更像人了，有惊喜但提升微妙","url":"https://stock-news.laohu8.com/highlight/detail?id=2514354332","media":"AI寒武纪","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514354332?lang=zh_cn&edition=full","pubTime":"2025-02-28 07:11","pubTimestamp":1740697866,"startTime":"0","endTime":"0","summary":"北京时间凌晨4点钟OpenAI举行一个14分钟左右的直播发布，GPT4.5 终于发布了！知识更渊博，能力更全面除了情商升级， GPT-4.5 的知识储备和能力也得到了显著提升。这次的 GPT-4.5 更是吊足了大家的胃口，毕竟距离 GPT-4 发布已经过去大约两年了！GPT-4: 感觉确实更好，但 Karpathy 也坦言，提升是 微妙的 。GPT-4.5：微妙的提升，依旧令人兴奋带着对 GPT-4 这种“微妙提升”的预期，Karpathy 对 GPT-4.5 进行了测试。这次 GPT-4.5 的预训练算力比 GPT-4 又提升了 10 倍！","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8hKW1DoEdqM","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fenghuang_stock","symbols":["EQ","BK4139","BK4108","BK4568","BK4531","BK4526","BK4552","BK4505"],"gpt_icon":1},{"id":"2514531453","title":"ChatGPT4.5凌晨发布：不是推理模型，胜似推理模型","url":"https://stock-news.laohu8.com/highlight/detail?id=2514531453","media":"凤凰网科技","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514531453?lang=zh_cn&edition=full","pubTime":"2025-02-28 05:31","pubTimestamp":1740691902,"startTime":"0","endTime":"0","summary":"凤凰网科技讯 2月28日，OpenAI发布了旗下最新一代大语言模型GhatGPT4.5。相较于GPT-4，GPT-4.5在多个方面进行了优化。GPT-4.5在用户交互中的表现更加自然，知识覆盖面更广，能更好地理解并响应用户的意图。回答问题更加严谨GPT-4.5的核心进展在于其无监督学习的提升。通过增加计算能力和数据规模，GPT-4.5在处理复杂任务时显示出更高的准确性，尤其是在减少“幻觉”现象方面表现突出。OpenAI表示，GPT-4.5仍处于研究预览阶段，未来将继续优化，以便更好地服务于各行各业的需求。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8hKW1DoEdbw","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"ifeng_tech","symbols":["BK4139","EQ","BK4568"],"gpt_icon":0},{"id":"2514132339","title":"Equillium, Inc.盘中异动 股价大涨5.87%报0.810美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514132339","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514132339?lang=zh_cn&edition=full","pubTime":"2025-02-28 02:59","pubTimestamp":1740682746,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日02时59分，Equillium, Inc.股票出现波动，股价大幅上涨5.87%。截至发稿，该股报0.810美元/股，成交量2.9874万股，换手率0.08%，振幅6.54%。Equillium, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，Pepgen Inc.、Ibio, Inc.、Quoin Pharmaceuticals Ltd涨幅较大，Quoin Pharmaceuticals Ltd、Aeon Biopharma, Inc.、Vincerx Pharma, Inc.较为活跃，换手率分别为1880.38%、320.93%、136.91%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Pds Biotechnology Corporation、Pepgen Inc.，振幅分别为86.14%、55.84%、52.94%。Equillium, Inc.公司简介：Equillium Inc 是一家开发治疗自身免疫和炎症疾病的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280259069632e33a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280259069632e33a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","EQ","BK4139"],"gpt_icon":0},{"id":"2514866643","title":"Equillium, Inc.盘中异动 快速跳水5.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514866643","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514866643?lang=zh_cn&edition=full","pubTime":"2025-02-27 02:07","pubTimestamp":1740593254,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日02时07分，Equillium, Inc.股票出现异动，股价急速下跌5.78%。Equillium, Inc.股票所在的生物技术行业中，整体跌幅为0.39%。其相关个股中，Enveric Biosciences, Inc.、Pds Biotechnology Corporation、Renovaro Inc.涨幅较大，Enveric Biosciences, Inc.、Aeon Biopharma, Inc.、Organovo Holdings, Inc.较为活跃，换手率分别为6400.71%、261.96%、239.71%，振幅较大的相关个股有Enveric Biosciences, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Pds Biotechnology Corporation，振幅分别为194.07%、49.18%、44.44%。Equillium, Inc.公司简介：Equillium Inc 是一家开发治疗自身免疫和炎症疾病的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227020734a255286e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227020734a255286e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4139","EQ"],"gpt_icon":0},{"id":"2514539578","title":"梅赛德斯-奔驰将逐步淘汰电动汽车“EQ+X”命名，以“配备 EQ 技术”取代","url":"https://stock-news.laohu8.com/highlight/detail?id=2514539578","media":"IT之家","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514539578?lang=zh_cn&edition=full","pubTime":"2025-02-26 10:26","pubTimestamp":1740536777,"startTime":"0","endTime":"0","summary":"根据外媒 Automotive News Europe 报道，梅赛德斯-奔驰正逐步淘汰电动汽车上的 EQ 前缀，未来将改用“配备 EQ 技术”后缀 ，而插电式混合动力车型则会添加“配备 EQ 混合动力技术”标签。梅赛德斯-奔驰的一位发言人表示，“我们正在强化传统的命名逻辑，未来新车型将不再使用‘EQ’。”梅赛德斯-奔驰并非唯一调整命名的欧洲豪华品牌。","market":"hk","thumbnail":"https://k.sinaimg.cn/n/spider20250226/697/w959h538/20250226/cec8-2c1c922f81bf06deb8a90e9f413caf31.jpg/w120h90l50t15f2.jpg","type":0,"news_type":0,"thumbnails":["https://k.sinaimg.cn/n/spider20250226/697/w959h538/20250226/cec8-2c1c922f81bf06deb8a90e9f413caf31.jpg/w120h90l50t15f2.jpg"],"rights":{"source":"sina_tech","url":"https://tech.sina.cn/mobile/xp/2025-02-26/detail-inemukxn8238835.d.html?vt=4","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}.weibo_user{#sourceStyle#; margin-bottom: 0; display: inline-block;}.weibo_time{#sourceStyle#};","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .j_float_wbro, .j_article_wbreco","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://tech.sina.cn/mobile/xp/2025-02-26/detail-inemukxn8238835.d.html?vt=4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina_tech","symbols":["BK4139","EQ","BK4568"],"gpt_icon":0},{"id":"2514001149","title":"Equillium, Inc.盘中异动 快速跳水6.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514001149","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514001149?lang=zh_cn&edition=full","pubTime":"2025-02-26 00:21","pubTimestamp":1740500464,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日00时21分，Equillium, Inc.股票出现波动，股价快速下跌6.19%。Equillium, Inc.股票所在的生物技术行业中，整体涨幅为0.56%。其相关个股中，Organovo Holdings, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Silexion Therapeutics Corp涨幅较大，Organovo Holdings, Inc.、Gt Biopharma, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为1323.39%、1114.16%、898.01%，振幅较大的相关个股有Organovo Holdings, Inc.、Silexion Therapeutics Corp、Abpro Holdings Inc C/Wts 12/11/2029 ，振幅分别为224.93%、87.83%、66.67%。Equillium, Inc.公司简介：Equillium Inc 是一家开发治疗自身免疫和炎症疾病的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226002105a2539ffe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226002105a2539ffe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4139","EQ"],"gpt_icon":0},{"id":"2513720385","title":"Equillium, Inc.盘中异动 股价大跌5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513720385","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513720385?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:59","pubTimestamp":1740409191,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时59分，Equillium, Inc.股票出现波动，股价快速下挫5.44%。Equillium, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。其相关个股中，Pepgen Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Telix Pharmaceutic涨幅较大，Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为150.95%、65.71%、25.12%，振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 ，振幅分别为137.23%、55.69%、41.14%。Equillium, Inc.公司简介：Equillium Inc 是一家开发治疗自身免疫和炎症疾病的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224225951a2521b52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224225951a2521b52&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4139","EQ"],"gpt_icon":0},{"id":"2512517165","title":"Equillium, Inc.盘中异动 早盘大幅下挫7.23%报0.872美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512517165","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512517165?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:37","pubTimestamp":1739889427,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时37分，Equillium, Inc.股票出现异动，股价快速跳水7.23%。截至发稿，该股报0.872美元/股，成交量1.1344万股，换手率0.03%，振幅3.19%。Equillium, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。Equillium, Inc.公司简介：Equillium Inc 是一家开发治疗自身免疫和炎症疾病的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223707a24aae1b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223707a24aae1b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4139","EQ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.equilliumbio.com","stockEarnings":[{"period":"1week","weight":0.0265},{"period":"1month","weight":0.3478},{"period":"3month","weight":0.8452},{"period":"6month","weight":0.3596},{"period":"1year","weight":0.7435},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0084},{"period":"1month","weight":-0.0046},{"period":"3month","weight":0.0296},{"period":"6month","weight":0.0754},{"period":"1year","weight":0.1431},{"period":"ytd","weight":0.0147}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Equillium, Inc.于2017年3月16日在特拉华州注册成立，该公司前身为Attenuate Biopharmaceuticals，Inc.。该公司是一家临床阶段的生物技术公司，利用对免疫生物学的深刻理解来开发新的疗法，以治疗具有高度未满足医疗需求的严重自身免疫和炎症，或免疫炎症疾病。公司战略专注于推进候选产品的临床开发，包括潜在地寻求额外的适应症和获得新的候选产品和平台以扩大管道。该公司打算独立或通过合作伙伴关系将候选产品商业化，或通过战略交易将公司管道货币化。","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.054449},{"month":2,"riseRate":0.625,"avgChangeRate":0.298849},{"month":3,"riseRate":0.285714,"avgChangeRate":-0.190483},{"month":4,"riseRate":0.285714,"avgChangeRate":-0.137456},{"month":5,"riseRate":0.714286,"avgChangeRate":0.036577},{"month":6,"riseRate":0.142857,"avgChangeRate":-0.151956},{"month":7,"riseRate":0.571429,"avgChangeRate":0.329165},{"month":8,"riseRate":0.714286,"avgChangeRate":0.556288},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.085401},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.070521},{"month":11,"riseRate":0.25,"avgChangeRate":-0.089283},{"month":12,"riseRate":0.5,"avgChangeRate":-0.014533}],"exchange":"NASDAQ","name":"Equillium Inc.","nameEN":"Equillium Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Equillium Inc.(EQ)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Equillium Inc.(EQ)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Equillium Inc.,EQ,Equillium Inc.股票,Equillium Inc.股票老虎,Equillium Inc.股票老虎国际,Equillium Inc.行情,Equillium Inc.股票行情,Equillium Inc.股价,Equillium Inc.股市,Equillium Inc.股票价格,Equillium Inc.股票交易,Equillium Inc.股票购买,Equillium Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Equillium Inc.(EQ)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Equillium Inc.(EQ)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}